These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 30304263

  • 1. Diagnostic significance of immunoglobulin G avidity in symptomatic and asymptomatic West Nile virus infection.
    Vilibic-Cavlek T, Kristofic B, Savic V, Kolaric B, Barbic L, Tabain I, Peric L, Sabadi D, Miklausic B, Potocnik-Hunjadi T, Zember S, Stevanovic V, Listes E, Savini G.
    Rev Soc Bras Med Trop; 2018; 51(5):591-595. PubMed ID: 30304263
    [Abstract] [Full Text] [Related]

  • 2. Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus.
    Levett PN, Sonnenberg K, Sidaway F, Shead S, Niedrig M, Steinhagen K, Horsman GB, Drebot MA.
    J Clin Microbiol; 2005 Dec; 43(12):5873-5. PubMed ID: 16333069
    [Abstract] [Full Text] [Related]

  • 3. Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus.
    Fox JL, Hazell SL, Tobler LH, Busch MP.
    Clin Vaccine Immunol; 2006 Jan; 13(1):33-6. PubMed ID: 16425997
    [Abstract] [Full Text] [Related]

  • 4. Serological screening of West Nile virus among blood donors in northern Cyprus.
    Balaman N, Gazi U, Imir T, Sanlidag T, Ruh E, Tosun O, Ozkul A, Taylan-Ozkan A.
    J Med Virol; 2020 Aug; 92(8):1035-1039. PubMed ID: 31925797
    [Abstract] [Full Text] [Related]

  • 5. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.
    Prince HE, Tobler LH, Lapé-Nixon M, Foster GA, Stramer SL, Busch MP.
    J Clin Microbiol; 2005 Sep; 43(9):4316-20. PubMed ID: 16145071
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Persistence of West Nile virus-specific antibodies in viremic blood donors.
    Prince HE, Tobler LH, Yeh C, Gefter N, Custer B, Busch MP.
    Clin Vaccine Immunol; 2007 Sep; 14(9):1228-30. PubMed ID: 17652525
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses.
    Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, Petersen LR.
    Vector Borne Zoonotic Dis; 2005 Sep; 5(2):137-45. PubMed ID: 16011430
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. First outbreak of West Nile virus neuroinvasive disease in humans, Croatia, 2012.
    Pem-Novosel I, Vilibic-Cavlek T, Gjenero-Margan I, Pandak N, Peric L, Barbic L, Listes E, Cvitkovic A, Stevanovic V, Savini G.
    Vector Borne Zoonotic Dis; 2014 Jan; 14(1):82-4. PubMed ID: 24283515
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.